IFM Investors Pty Ltd Acquires New Stake in Mettler-Toledo International, Inc. $MTD

IFM Investors Pty Ltd bought a new position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) in the 1st quarter, HoldingsChannel.com reports. The institutional investor bought 3,854 shares of the medical instruments supplier’s stock, valued at approximately $4,861,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Geneos Wealth Management Inc. grew its position in shares of Mettler-Toledo International by 83.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after buying an additional 30 shares during the last quarter. Baird Financial Group Inc. raised its position in shares of Mettler-Toledo International by 3.1% during the second quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock worth $1,582,000 after acquiring an additional 40 shares during the last quarter. Jump Financial LLC lifted its stake in shares of Mettler-Toledo International by 44.6% in the second quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock worth $476,000 after acquiring an additional 125 shares during the period. Cerity Partners LLC lifted its stake in shares of Mettler-Toledo International by 10.8% in the second quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock worth $4,740,000 after acquiring an additional 392 shares during the period. Finally, AXA S.A. boosted its holdings in Mettler-Toledo International by 2.9% in the second quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock valued at $5,433,000 after acquiring an additional 131 shares during the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

MTD has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. decreased their target price on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a research report on Monday, May 11th. Barclays dropped their price target on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Citigroup lowered their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a research note on Friday, May 8th. Finally, Robert W. Baird dropped their target price on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $1,408.55.

Mettler-Toledo International Stock Down 0.0%

NYSE MTD opened at $1,307.91 on Friday. The business has a 50 day moving average price of $1,175.53 and a 200-day moving average price of $1,290.11. The company has a market cap of $26.43 billion, a price-to-earnings ratio of 30.67, a P/E/G ratio of 2.73 and a beta of 1.24. Mettler-Toledo International, Inc. has a 52 week low of $1,023.05 and a 52 week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share for the quarter, beating the consensus estimate of $8.70 by $0.21. The business had revenue of $947.13 million for the quarter, compared to analysts’ expectations of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The business’s revenue was up 7.2% on a year-over-year basis. During the same period last year, the business earned $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.